Browse

The likelihood of snagging NIH grants has plunged to historic lows, forcing academic researchers to resort to a variety of tactics to try to obtain funding

Michael Burgess and Larry Bucshon, former Republican congressmen and doctors, weigh in on RFK Jr.’s recent congressional hearings.

The biotech will use the proceeds to develop inhalable versions of therapies already on the market for the “idiopathic” and “progressive” forms of pulmonary fibrosis.